National Bank of Canada’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20 | Hold |
50
| – | – | ﹤0.01% | 2559 |
|
|
2025
Q1 | $16 | Hold |
50
| – | – | ﹤0.01% | 2458 |
|
|
2024
Q4 | $21 | Sell |
50
-115
| -70% | -$48 | ﹤0.01% | 2468 |
|
|
2024
Q3 | $162 | Buy |
165
+115
| +230% | +$113 | ﹤0.01% | 2349 |
|
|
2024
Q2 | $83 | Hold |
50
| – | – | ﹤0.01% | 2486 |
|
|
2024
Q1 | $73 | Hold |
50
| – | – | ﹤0.01% | 2483 |
|
|
2023
Q4 | $142 | Hold |
50
| – | – | ﹤0.01% | 2466 |
|
|
2023
Q3 | $212 | Hold |
50
| – | – | ﹤0.01% | 2463 |
|
|
2023
Q2 | $438 | Hold |
50
| – | – | ﹤0.01% | 2453 |
|
|
2023
Q1 | $153 | Hold |
50
| – | – | ﹤0.01% | 2504 |
|
|
2022
Q4 | $605 | Hold |
50
| – | – | ﹤0.01% | 2460 |
|
|
2022
Q3 | $0 | Sell |
50
-61
| -55% | – | ﹤0.01% | 2519 |
|
|
2022
Q2 | $2K | Hold |
111
| – | – | ﹤0.01% | 2375 |
|
|
2022
Q1 | $1K | Hold |
111
| – | – | ﹤0.01% | 2525 |
|
|
2021
Q4 | $2K | Buy |
+111
| New | +$2K | ﹤0.01% | 2430 |
|